Production (Stage)
BioLife Solutions, Inc.
BLFS
$21.78
-$0.32-1.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 95.62% | 183.30% | 94.15% | -- | 25.47% |
| Total Depreciation and Amortization | -39.24% | 35.76% | -27.07% | -- | -28.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -25.45% | -171.94% | -77.07% | -- | -26.95% |
| Change in Net Operating Assets | -42.55% | -84.02% | 39.59% | -- | -378.95% |
| Cash from Operations | 138.59% | -28.82% | 209.66% | 183.69% | -65.01% |
| Capital Expenditure | 48.17% | 66.36% | 35.42% | -- | 80.91% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4,565.94% | 1,073.93% | -103.28% | -- | -91.71% |
| Cash from Investing | -12,196.83% | 1,760.93% | -201.14% | -244.59% | -107.55% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -937.34% | -1,951.89% | -535.60% | -- | -89.76% |
| Issuance of Common Stock | -- | -99.37% | -28.13% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 30.80% | 0.00% | 67.56% | -- | -26.96% |
| Cash from Financing | -214.29% | -141.52% | -271.22% | -200.00% | -69.40% |
| Foreign Exchange rate Adjustments | -- | -53.97% | 164.29% | -- | -690.91% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -397.83% | 340.42% | 197.74% | -434.64% | -1,595.25% |